Crossroads Neurovascular, Inc. FDA Approvals

0 new drug approvals and 2 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
PATH BGC510(k)Apr 15, 2026Cardiovascular	Cardiovascular	510(k)Substantially Equivalent (Special)	Apr 15, 2026
PATH BGC510(k)May 9, 2025Cardiovascular	Cardiovascular	510(k)Substantially Equivalent (Traditional)	May 9, 2025